XGN Stock Analysis: Buy, Sell, or Hold?
XGN - Exagen Inc. Common Stock
$3.01
0.01 (0.33%)
▲
5d:
+4.51%
30d:
-12.24%
90d:
-49.92%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
XGN is down 5.7% this week, but smart money is accumulating calls. Top strike: $5 2026-04-17 with 20 OI. Call ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When XGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XGN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: XGN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: XGN is currently trading at $3.01, which is considered slightly low relative to its 30-day fair value range of $2.85 to $3.53.
Technical Outlook: Technically, XGN is in a strong downtrend. Immediate support is located at $2.59, while resistance sits at $3.21.
Market Sentiment: XGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+215.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XGN is in a strong downtrend. Immediate support is located at $2.59, while resistance sits at $3.21.
Market Sentiment: XGN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+215.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$2.85 -
$3.53
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 215.6% below Wall St target ($9.50)
Fair Price Analysis
30-Day Fair Range
$2.85 -
$3.53
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.59
Resistance Level
$3.21
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.71
Wall Street Target
$9.50
(+215.6%)
Revenue Growth (YoY)
21.8%
Profit Margin
-30.0%
Share & Embed Analysis
Last updated: April 02, 2026 9:36 AM ET
Data refreshes hourly during market hours. Next update: 10:36 AM
Data refreshes hourly during market hours. Next update: 10:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
John Aballi
SELL
15698 shares
2026-03-03
John Aballi
SELL
11430 shares
2026-02-24
John Aballi
SELL
31787 shares
2025-10-16
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
